MedCap AB (MEDCAP)

Stockholm

Currency in SEK

587.000

+31.000(+5.58%)

Closed00:30:59

Fair Value

Day's Range

552.000

589.000

52 wk Range

302.500

624.000

MEDCAP Income Statement

Featured here, the Income Statement (earnings report) for MedCap AB, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

30/04

2016

30/04

2017

30/04

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

757.4

828

926.3

1,124

1,599.7

Total Revenues Growth

+6.78%

+9.32%

+11.87%

+21.34%

+42.32%

Cost Of Revenues

322

350.2

357.7

446.8

661

Gross Profit

435.4

477.8

568.6

677.2

938.7

Gross Profit Growth

+15.49%

+9.74%

+19%

+19.1%

+38.61%

Gross Profit Margin %

57.49%

57.71%

61.38%

60.25%

58.68%

Other Operating Expenses, Total

356.9

404.8

464.8

528.1

713

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+6.54%	+13.42%	+14.82%	+13.62%	+35.01%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	294.2	329.2	384.6	443.5	601.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5.9	7.5	4.7	3.3	7.9

Operating Income

78.5

73

103.8

149.1

225.7

Operating Income Growth

+86.9%

-7.01%

+42.19%

+43.64%

+51.37%

EBIT Margin %

10.36%

8.82%

11.21%

13.27%

14.11%

Net Interest Expenses

-9

-8

-9

-14.1

-8.6

Net Interest Expenses Growth

-233.33%

+11.11%

-12.5%

-56.67%

+39.01%

Interest Expense, Total

-9.3

-9.1

-9.4

-16.4

-15.6

Interest And Investment Income

0.3

1.1

0.4

2.3

7

Other Non Operating Expenses, Total

2.8

11.7

3

2.9

14.8

EBT, Excl. Unusual Items

72.3

76.7

97.8

137.9

231.9

Gain (Loss) On Sale Of Assets

-

-

4

20

-

Other Unusual Items, Total

-

4.8

15.2

-5.9

0.8

EBT, Incl. Unusual Items

72.3

81.5

117

152

222.3

EBT, Incl. Unusual Items Growth

+79.4%

+12.72%

+43.56%

+29.91%

+46.25%

EBT, Incl. Unusual Items Margin

9.55%

9.84%

12.63%

13.52%

13.9%

Income Tax Expense

14.6

17

18.9

34

49.8

Net Income to Company

56.2

62.8

98.1

118

172.5

Minority Interest

-2.5

-1.9

-1.6

-0.4

-0.3

Net Income

53.7

60.9

96.5

117.6

172.2

Net Income Growth

+8,850%

+13.41%

+58.46%

+21.87%

+46.43%

Net Income Margin %

7.09%

7.36%

10.42%

10.46%

10.76%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

55.2

62.6

96.5

117.6

172.2

Basic EPS - Continuing Operations

4.1

4.36

6.52

7.94

11.63

Basic EPS - Continuing Operations Growth

+125.82%

+6.29%

+49.46%

+21.82%

+46.43%

Diluted EPS - Continuing Operations

4.1

4.36

6.5

7.9

11.6

Diluted EPS - Continuing Operations Growth

+127.78%

+6.39%

+49.02%

+21.54%

+46.84%

Basic Weighted Average Shares Outstanding

13.45

14.35

14.8

14.81

14.81

Diluted Weighted Average Shares Outstanding

13.45

14.36

14.8

14.81

14.86

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

101.8

104.3

141.1

188.6

277.8

EBITDA Growth

+52.85%

+2.46%

+35.28%

+33.66%

+47.3%

EBITDA Margin %

13.44%

12.6%

15.23%

16.78%

17.37%

EBIT

78.5

73

103.8

149.1

225.7

* In Millions of SEK (except for per share items)